DNA X Amends 8-K: $5.6M Series B Preferred Financing Lifts Pro Forma Equity Above Nasdaq Minimum
SONM sits 60% above its 52-week low of $2.521.
Summary
DNA X amended its July 2 financing disclosure, revealing it issued 929,864 Series B preferred shares for $5.6 million in total consideration and now believes it meets Nasdaq's equity listing rule with $3.8 million in pro forma stockholders' equity.
Key Events · Financing and Capital Events · SONM
-
Series B Preferred Financing Details
Issued 929,864 shares of Series B Preferred Stock for $2.5 million cash and cancellation of $3.1 million in convertible debt, totaling $5.6 million in consideration.
-
Remaining Shares to Be Issued
An additional 416,667 shares are expected to be sold by August 14, 2026, under the purchase agreement.
-
Nasdaq Compliance Update
Pro forma stockholders' equity estimated at $3.8 million as of July 9, 2026, exceeding the $2.5 million Nasdaq minimum; company awaits formal determination.
-
Certificate of Designation Filed
Filed with Delaware on July 6, 2026, establishing the rights and preferences of the Series B Preferred Stock.
Analysis · SONM · Manufacturing
The specific terms of DNA X's Series B Preferred Stock financing have now been disclosed: 929,864 shares were issued for $2.5 million in cash and $3.1 million in debt cancellation. Another 416,667 shares are expected by August 14. Crucially, the company estimates pro forma stockholders' equity of $3.8 million, which exceeds Nasdaq's $2.5 million continued listing threshold—a direct response to the May 27 delisting notice. This amendment transforms the original 8-K's vague announcement into a concrete path to regaining compliance, though the equity boost hinges on the full closing of the deal.
How filings like this one have moved
In the 30 days to Aug 23, 2026, 37.5% of the 3432 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, SONM was trading at $4.03 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $6M. The 52-week trading range was $2.52 to $16.97. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.